Nancy King to Disclosure
This is a "connection" page, showing publications Nancy King has written about Disclosure.
Connection Strength
1.520
-
King NMP. Key Information in the New Common Rule: Can It Save Research Consent? J Law Med Ethics. 2019 06; 47(2):203-212.
Score: 0.686
-
King NM. There's a lot we don't know (and we ought to say so). Am J Bioeth. 2013; 13(12):20-1.
Score: 0.440
-
King NM. Nanomedicine first-in-human research: challenges for informed consent. J Law Med Ethics. 2012; 40(4):823-30.
Score: 0.103
-
King NM, Henderson G. Treatments of last resort: informed consent and the diffusion of new technology. Mercer Law Rev. 1991; 42(3):1007-50.
Score: 0.096
-
Weinfurt KP, Hall MA, King NM, Friedman JY, Schulman KA, Sugarman J. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 Aug 27; 361(9):916-21.
Score: 0.087
-
King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS. Consent forms and the therapeutic misconception: the example of gene transfer research. IRB. 2005 Jan-Feb; 27(1):1-8.
Score: 0.063
-
Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. J Law Med Ethics. 2012; 40(4):1008-24.
Score: 0.026
-
Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NM, Lidz CW, Miller FG, Nelson DK, Peppercorn J, Rothschild BB, Sankar P, Wilfond BS, Zimmer CR. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007 Nov 27; 4(11):e324.
Score: 0.019